Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 30839
Event :4th Microbiome Movement - Drug Development Summit Europe 2020 - London, UK

Dates :Tuesday February 04th, 2020 - Thursday February 06th, 2020

Location :The Tower Hotel
St Katharine's Way
E1W 1LD London, United Kingdom

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

 

 

Part of the foremost conference series for microbiome researchers in industry, the 4th Microbiome Movement – Drug Development Europe 2020 returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.

Across three days of case-studies, discussion and debates, learn how industry and academic leaders are understanding microbiome functionality across key therapeutic modalities, leveraging big data platforms to deduce causality, and overcoming regulatory, clinical and manufacturing hurdles to further accelerate their pipeline across new disease targets.

At this critical time, and as the microbiome community waits for the first clinical breakthrough, join your peers and unlock the potential of the human microbiome to create the next generation of microbiome-based therapeutics and diagnostic candidates of the future.

Early booking and group discounts apply, start-up and academic rates are available - see the website for details.

Prices:

Drug Developers: Pharma and Biotech- Standard Pricing- Conference + 2 Workshops: GBP 2397.00,
Drug Developers: Pharma and Biotech- Standard Pricing- Conference + 1 Workshop: GBP 2098.00,
Drug Developers: Pharma and Biotech- Standard Pricing- Conference Only: GBP 1799.00,
Drug Developers: Pharma and Biotech- Standard Pricing- Conference + 3 Workshops: GBP 2696.00,
Start-Up, Academic and Not For Profit - Standard Pricing- Conference + 3 Workshops: GBP 2296.00,
Start-Up, Academic and Not For Profit - Standard Pricing- Conference + 2 Workshops: GBP 1997.00,
Start-Up, Academic and Not For Profit - Standard Pricing- Conference + 1 Workshop: GBP 1698.00,
Start-Up, Academic and Not For Profit - Standard Pricing- Conference Only: GBP 1399.00
Workshop Only: GBP 399.00

URLs:

Website: https://go.evvnt.com/534064-0?pid=4319

Tickets: https://go.evvnt.com/534064-2?pid=4319

Brochure: https://go.evvnt.com/534064-3?pid=4319

Speakers: Lothar Steidler, Chief Technology Officer, ActoBio Therapeutics, Andrea Doolan, CEO, Atlantia Food Clinical Trials, Rikke Nielsen, CEO and Founder, Beo Therapeutics, Adrien Nivoliez, CEO, biose industrie, Elran Haber, CEO, Biomica Ltd., Assaf Oron, Chief Business Officer, BiomX, Dora Nagy-Szakal, CMO, Biotia, Inc., Jeffrey Heiser, Director Microbiology, Boston Analytical, Luc Sterkman, CEO, Caelus Health, Arne Materna, Vice President Product, CosmosID, Jean de Gunzburg, CSO, DaVolterra, Sebastien Guery, Human Microbiome Venture Leader, Dupont Microbiome Venture, Igor Stzepourginski, Head of Preclinical Operations, Eligo Biosciences, Romain D’Ailiere, Head of Preclinical Research and Co-Founder, EverImmune, Rafael Suarez, Senior Director Emerging Brands, Global Marketing, Gastroenterology and Mirobiome, Ferring Pharmaceuticals, Kristin Wannerberger, Director R&D Alliance Management, Ferring Pharmaceuticals, Anna Williamson, Senior Director Oncology Business and Head of UK Business Development, Genentech, Suhyun Kim, Postdoctoral fellow, Harvard University, Shahram Lavasani, CEO and Founder, Immune Biotech, Georges Rawadi, CEO, LNC Therapeutics, Jason Ryan, Upstream Manager, Luina Bio, Sophie Durand, Co-Founder, Microbiome Foundation, Mike Romanos, CEO, Microbiotica, Trevor Lawley, CSO, Microbiotica, Herwig Bachmann, Expertise Group Leader, Fermentation NIZO, Maria Akerman, Director Process R&D, Oxthera, Tomas de Wouters, CEO and Co-Founder, PharmaBIome, Aurelien Baudot, International Business Developer, ProDigest, Ryan Wilson, Head of Live-Bio Programmes, Quay Pharma, Ken Blount, CSO, Rebiotix, Alain Roulet, Laboratory Director, Vaiomer, Kareem Barghout, Co-Founder, VastBiome, Bruce Roberts, CSO, Vedanta Biosciences, Imke Mulder, Director of Research, 4D Pharma, Damien Keogh, CEO, Maiden Therapeutics, Christophe Lacroix, Professor, Food Biotechnology, ETH Zuric

Time: 8:30 am - 5:50 pm

Location

Map and directions
Conference address :
The Tower Hotel
St Katharine's Way
E1W 1LD London
United Kingdom
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

4th Microbiome Movement - Drug Development Summit Europe 2020 - London, UK Medicine
--
Everyone
-- -- --
English

Other

For more information on 4th Microbiome Movement - Drug Development Summit Europe 2020 - London, UK, plsase contactr Customer Services

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event